Detalles de la búsqueda
1.
A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.
Bioorg Med Chem Lett
; 18(2): 674-8, 2008 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18061446
2.
Palladium- and ruthenium-catalyzed cycloisomerization of enynamides and enynhydrazides: a rapid approach to diverse azacyclic frameworks.
Angew Chem Int Ed Engl
; 52(35): 9139-43, 2013 Aug 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-23857937
3.
Discovery and optimization of a series of carbazole ureas as NPY5 antagonists for the treatment of obesity.
J Med Chem
; 45(16): 3509-23, 2002 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12139462
4.
Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): a potent and selective inhibitor of ATR protein kinase with monotherapy in vivo antitumor activity.
J Med Chem
; 56(5): 2125-38, 2013 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-23394205
5.
Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.
Bioorg Med Chem Lett
; 17(22): 6326-9, 2007 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17869514
Resultados
1 -
5
de 5
1
Próxima >
>>